This document discusses meta-analysis, which involves systematically combining results from multiple studies to derive conclusions about a body of research. It describes the key steps in conducting a meta-analysis, including writing a research question and protocol, performing a comprehensive literature search, selecting studies, assessing study quality, extracting data, and analyzing data. Statistical methods for pooling results across studies using fixed and random effects models are also outlined. The document highlights strengths and limitations of meta-analysis for providing more precise estimates of treatment effects and identifying areas needing further research.
Introduction to meta-analysis (1612_MA_workshop)Ahmed Negida
Chapter 1: Introduction to Meta-analysis
- From the 1612 MA Workshop that will be held on 11th, December, 2016 at Dokki, Giza, Egypt
- Workshop instructor: Mr. Ahmed Negida, MBBCh candidate
Introduction to meta-analysis (1612_MA_workshop)Ahmed Negida
Chapter 1: Introduction to Meta-analysis
- From the 1612 MA Workshop that will be held on 11th, December, 2016 at Dokki, Giza, Egypt
- Workshop instructor: Mr. Ahmed Negida, MBBCh candidate
Meta-analysis in Epidemiology is:
Useful tool for epidemiological studies which investigates the relationships between certain risk factors and disease.
Useful tool to improve animal well-being and productivity
Despite of a wealth of suitable studies it is relatively underutilized in animal and veterinary science.
Meta-analysis can provide reliable results about diseases occurrence, pattern and impact in livestock.
It is utmost essential to take benefit of this statistical tool for produce. more reliable estimates of concern effects in animal and veterinary science data.
Summary slides for "Systematic Review and Meta-Analysis Course for Healthcare Professionals", January 8-9, 2013, King Abdullah Medical City, Makkah, Saudi Arabia
http://KAMCResearch.org
5 essential steps for sample size determination in clinical trials slidesharenQuery
In this free webinar hosted by nQuery Researcher & Statistician Eimear Keyes, we map out the 5 essential steps for sample size determination in clinical trials. At each step, Eimear will highlight the important function it plays and how to avoid the errors that will negatively impact your sample size determination and therefore your study.
Watch the Video: https://www.statsols.com/webinar/the-5-essential-steps-for-sample-size-determination
This workshop is meant to be an introduction to the systematic review process. Further information about systematic reviews was available through a research guide. http://libguides.ucalgary.ca/content.php?pid=593664
Basics of Systematic Review and Meta-analysis: Part 3Rizwan S A
A 4 part lecture series on the basics of Systematic Review and Meta-analysis, Part 3 discusses the software needed and analytical techniques used for this purpose.
An introduction on how to go about a meta-analysis. Primarily designed for people with non statistical background. Heavily borrows from Cochrane Handbook of Systematic Reviews of Interventions.
Title:
A Meta-Analysis of Adventure Therapy Outcomes and Moderators
Abstract:
This presentation reports on a meta-analytic review of 197 studies of adventure therapy participant outcomes (2,908 effect sizes, 206 unique samples). The short-term effect size for adventure therapy was moderate (g = .47) and larger than for alternative (.14) and no treatment (.08) comparison groups. There was little change during the lead-up (.09) and follow-up periods (.03) for adventure therapy, indicating long-term maintenance of the short-term gains. The short-term adventure therapy outcomes were significant for seven out of the eight outcome categories, with the strongest effects for clinical and self-concept measures, and the smallest effects for spirituality/morality. The only significant moderator of outcomes was a positive relationship with participant age.
References:
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators. The Open Psychology Journal, 6, 28-53. doi: 10.2174/1874350120130802001
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators: Pre-post adventure therapy age-based benchmarks for outcome categories. Retrieved from http://www.danielbowen.com.au/meta-analysis
For more information, see: http://www.danielbowen.com.au/meta-analysis
HEALTHCARE RESEARCH METHODS: Secondary and tertiary StudiesDr. Khaled OUANES
Secondary analyses are based on the use of pre-existing data sets and usually the researcher conducting the statistical analysis has not had any contact with the participants whose data are being examined.
A systematic review is, on the other hand, the thorough compilation and summary of all publications relevant to a particular research topic.
Meta-analysis in Epidemiology is:
Useful tool for epidemiological studies which investigates the relationships between certain risk factors and disease.
Useful tool to improve animal well-being and productivity
Despite of a wealth of suitable studies it is relatively underutilized in animal and veterinary science.
Meta-analysis can provide reliable results about diseases occurrence, pattern and impact in livestock.
It is utmost essential to take benefit of this statistical tool for produce. more reliable estimates of concern effects in animal and veterinary science data.
Summary slides for "Systematic Review and Meta-Analysis Course for Healthcare Professionals", January 8-9, 2013, King Abdullah Medical City, Makkah, Saudi Arabia
http://KAMCResearch.org
5 essential steps for sample size determination in clinical trials slidesharenQuery
In this free webinar hosted by nQuery Researcher & Statistician Eimear Keyes, we map out the 5 essential steps for sample size determination in clinical trials. At each step, Eimear will highlight the important function it plays and how to avoid the errors that will negatively impact your sample size determination and therefore your study.
Watch the Video: https://www.statsols.com/webinar/the-5-essential-steps-for-sample-size-determination
This workshop is meant to be an introduction to the systematic review process. Further information about systematic reviews was available through a research guide. http://libguides.ucalgary.ca/content.php?pid=593664
Basics of Systematic Review and Meta-analysis: Part 3Rizwan S A
A 4 part lecture series on the basics of Systematic Review and Meta-analysis, Part 3 discusses the software needed and analytical techniques used for this purpose.
An introduction on how to go about a meta-analysis. Primarily designed for people with non statistical background. Heavily borrows from Cochrane Handbook of Systematic Reviews of Interventions.
Title:
A Meta-Analysis of Adventure Therapy Outcomes and Moderators
Abstract:
This presentation reports on a meta-analytic review of 197 studies of adventure therapy participant outcomes (2,908 effect sizes, 206 unique samples). The short-term effect size for adventure therapy was moderate (g = .47) and larger than for alternative (.14) and no treatment (.08) comparison groups. There was little change during the lead-up (.09) and follow-up periods (.03) for adventure therapy, indicating long-term maintenance of the short-term gains. The short-term adventure therapy outcomes were significant for seven out of the eight outcome categories, with the strongest effects for clinical and self-concept measures, and the smallest effects for spirituality/morality. The only significant moderator of outcomes was a positive relationship with participant age.
References:
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators. The Open Psychology Journal, 6, 28-53. doi: 10.2174/1874350120130802001
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators: Pre-post adventure therapy age-based benchmarks for outcome categories. Retrieved from http://www.danielbowen.com.au/meta-analysis
For more information, see: http://www.danielbowen.com.au/meta-analysis
HEALTHCARE RESEARCH METHODS: Secondary and tertiary StudiesDr. Khaled OUANES
Secondary analyses are based on the use of pre-existing data sets and usually the researcher conducting the statistical analysis has not had any contact with the participants whose data are being examined.
A systematic review is, on the other hand, the thorough compilation and summary of all publications relevant to a particular research topic.
Pharmacoepidemiology is the study of effects of drugs in large numbers of people.
Epidemiologic Study Designs, Reasons to perform Pharmacoepidemiology studies, Users of pharmacoepidemiology and Role of Pharmacists & other Public Health Practitioners in Pharmacoepidemiology are discussed in this presentation.
An overview of the ICH E9 guidance. Easy to follow, and I can provide a live presentation of this to your team! Great for those who are not familiar with statistics.
Biostatistics in clinical research involves the application of statistical methods to analyze and interpret data from clinical trials. It plays a crucial role in study design, sample size determination, data analysis, and result interpretation. Biostatisticians ensure that clinical research findings are valid, reliable, and meaningful, contributing to evidence-based medicine. Their expertise helps researchers make informed decisions, assess treatment efficacy, and draw accurate conclusions about the safety and effectiveness of interventions.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
2. Introduction
▪ Types of review
▪ Definition
▪ Function of meta-analysis
Conducting Meta-analysis
▪ Writing the research question and protocol
▪ Comprehensive search
▪ Selection of studies
▪ Appraisal (quality assessment) of studies
▪ Data abstraction
▪ Data analysis
3. Effect size
Presenting the findings – Forest plot
Heterogeneity
Dealing with heterogeneity
▪ Fixed and random effects model
▪ Meta-regression
▪ IPD analysis
Strengths and Weaknesses of meta-analysis
Software for meta-analysis
4.
5. Information explosion
More than 1,00,000 articles are
published each year in more
than 20,000 journals.
Humanly impossible to read
through the articles
published in any field.
Publication bias
Concise summaries of literature
(Reviews) required, after
separating insignificant and
unsound from salient and
crucial.
7. “ review articles written by one or more experts based on a convenience
sample of studies with no description of the underlying methodology”
Confuse ‘absence of proof’ of benefit as ‘proof of absence’ of benefit
Do not statistically combine results from multiple studies
Vote-counting
8. “ a review addressing a specific research question using explicit
methodology of collecting, selecting and appraising studies and,
whenever appropriate, synthesizing their results quantitatively”
Has only qualitative or both qualitative and quantitative components
Quantitative component is meta-analysis
9. “Quantitative approach for systematically combining
results of previous research to arrive at conclusions
about the body of research.”
10. 1952: Hans J. Eysenck concluded that there were no favorable effects
of psychotherapy, starting a raging debate which 25 years of evaluation research
and hundreds of studies failed to resolve
1978: To proved Eysenck wrong, Gene V. Glass statistically
aggregated the findings of 375 psychotherapy outcome studies
Glass (and colleague Smith) concluded that psychotherapy did indeed
work.
Glass called the method “meta-analysis”
11. Underpinning ideas can be identified earlier:
K. Pearson (1904)
Averaged correlations for typhoid mortality after inoculation across 5 samples
R. A. Fisher (1944)
Source of the idea of cumulating probability values
W. G. Cochran (1953)
Discussed a method of averaging means across independent studies
Set out much of the statistical foundation for meta-analysis (e.g., Inverse variance
weighting and homogeneity testing)
12. Identify heterogeneity in effects among multiple studies and, where
appropriate, provide summary measure
Increase statistical power and precision to detect an effect
Develop ,refine, and test hypothesis
Reduce the subjectivity of study comparisons by using systematic and
explicit comparison procedure
Identify data gap in the knowledge base and suggest direction for future
research
Calculate sample size for future studies
Analyses if and how previous studies have modified knowledge on a
certain topic
13.
14. Writing the research question and a protocol
Comprehensive search
Selection of studies
Appraisal (quality assessment) of studies
Data abstraction
Data analysis
15. Research question:
▪ P: the population of interest
▪ I: the intervention or exposure
▪ C: the comparison (in certain situations)
▪ O: the outcome of interest
Protocol: specifying the –
▪ Research question
▪ Search methods
▪ Inclusion and exclusion criteria for studies
▪ Criteria for quality assessment (appraisal) of the studies
▪ Methods of data abstraction and synthesis
16. Cochrane Review of
magnesium
sulphate and other
anticonvulsants for
women with pre-eclampsia
17. Hand searching – ‘gold-standard’ for published studies
The percent (or proportion) of (relevant) studies found in electronic databases
compared to hand searching is termed as ‘sensitivity’; and percent or proportion of
the yield that is relevant is called ‘specificity’.
Computerized databases: Pubmed/Medline, EMBASE, Cochrane
Review/Trials Register
Personal references, and emails
Web, e.g. Google internet search engine (http://scholar.google.com)
Conference programs
Dissertations
Review articles
Government reports, bibliographies
18. Explicit Inclusion and exclusion criteria
Study designs: RCTs or CTs with a non-exercise control group
Subjects: Females > 18 years of age
Publication types: Journal articles, dissertations, & masters theses
Languages: English
Interventions: Bone mineral density assessed at femur, spine, and/or
radius
Time Frame: Studies published & indexed between January 1966 and
December 1998
20. Non-randomized trials:
Treatment allocation related to prognosis or pre-judgment of
appropriateness of treatment
Randomized trials:
Inadequate randomization (e.g., alternating assignment)
Lack of stratification on important factors
Lack of or ineffective blinding
All trials:
Patient drop-outs, patient switching arms
Missing data
Improper statistical analysis
21. Quality scores developed by -
▪ Chalmers et al
▪ Jadad et al
None is absolute best.
Little is known about their relative merits and their association with
study outcomes.
22. Reporting Bias
is a group of related biases potentially leading to over-representation of
significant or positive studies in systematic reviews
Studies with significant positive findings -
More likely to be published- Publication bias - over estimation of
treatment effects
More likely to be published rapidly - Time lag bias
More likely to be published in English - Language bias
More likely to be published more than once - Multiple publication bias
More likely to be cited by others - Citation bias
23. Funnel Plot:
Display the studies included in meta-analysis in a plot of effect size
against sample size (or some other measure of the extent to which the
findings could be affected by the play of chance).
Egger’s Regression Test:
Tests whether small studies tend to have larger effect sizes than would
be expected (implying that small studies with small effect sizes have
not been published).
Begg’s rank correlation test
25. An Asymmetric Funnel Plot
(indicative of publication bias)
(Region
of missing
studies)
-2 -1 0 1 2
Log Odds Ratio
Asymmetric plot –
•Publication bias
•Clinical heterogeneity
•Methodological heterogeneity
26. Combine the results of larger studies only, which are less likely subject to
publication bias.
File-drawer Method / Fail safe N: How many unpublished studies showing
a null result are required to change a ‘significant’ meta analysis result to a
‘non-significant’ one?
‘Trim and Fill’ method
28. At least two reviewers
Sift and sift again
▪ The first sift – pre-screening - is to decide which studies to retrieve in full.
▪ The second sift – selection - is to look again at these studies and decide which
are to be included in your review
Do not collect outcome data at the same time as eligibility information
▪ wasted time and effort - if study is excluded later on
▪ Results can sway decision
Look out for duplicate publications
29.
30. Create a spreadsheet (Excel, or Open Office Calc)
For each study, create the following columns:
name of the study
name of the author, year published
number of participants who received intervention
number of participants who were in control arm
number who developed outcomes in intervention
number who developed outcomes in control arm
31. 22 studies to do meta analysis
Seven columns created
trial: trial identity code
trialnam: name of trial
year: year of the study
pop1: study population
deaths1: deaths in study
pop0: control population
deaths0: deaths in control
32.
33. Choice of metric :
▪ Original
▪ Standardized mean difference (Mean/Standard Deviation)
Publication bias:
▪ Graphical methods
▪ Quantitative methods
Choice of model/ heterogeneity:
▪ Fixed Effects
▪ Random Effects
34. 35
Data Type Outcome Measures
Continuous Mean
Dichotomous (binary)
(displayed in 2x2 table)
Odds ratio (OR),
Risk ratio (RR),
Risk difference (RD)
35. For continuous outcomes, the mean difference (effect size) is usually used
to compare treatment and control groups
Effect sizes are standardized by the pooled estimate of the (common)
within-group variance
For skewed continuous outcomes,
values may be transformed (e.g. logarithmic), or
the median may be used
36
36. Failure Success
Treatment a b
Control c d
Odds: Treatment: a/b, Control: c/d
Odds Ratio =
ad
bc
a /
b
c d
/
OR < 1 implies treatment effectiveness (protective)
OR > 1 indicative of treatment inferiority (risk)
37. For the purposes of combining, analysis may be presented in
terms of log (OR), i.e. as a difference of log (Odds) of treatment
and control.
Var[log (OR)] =
1 1 1 1
a b c d
If any of the cell-counts is less than 5, use continuity correction
(add 0.5) before calculating OR.
38. a a b
/(
)
c /( c
d
)
RR =
RR is also called the Risk Ratio
It represents the probability of an event (failure) in the treatment
group relative to the probability of the same event in the control
group.
RR is analyzed in log scale.
Var[log(RR)] =
1 1 1 1
a a
b c c d
39. RD =
c
c d
a
a b
RD is the difference of two binomial probabilities, while
RR is the ratio.
Var(RD) =
,
p p
p p
(1 ) (1 ) 1 1 2 2
m
n
where n=a+b, m=c+d, p1= a/n, p2=c/m
40. Failure Success Total
New Treatment 5 95 100
Control 10 90 100
Odds Ratio = (5/95) / (10/90) = 0.48
Risk Ratio = (5/100) / (10/100) = 0.50
(Recall OR RR when probability is small. OR is generally more extreme (further from 1) than RR.)
Risk Difference = (5/100) - (10/100) = -0.05
41.
42. The effect size makes meta-analysis possible
“ratio of the frequency of the events in the intervention to that in the
control group.”
Any standardized index can be an “effect size” (e.g., standardized mean
difference, correlation coefficient, odds-ratio) as long as it –
Is comparable across studies (generally requires standardization)
Represents the magnitude and direction of the relationship of interest
Is independent of sample size
Different meta-analyses may use different effect size indices
47. The graphical display of results from individual studies on a common
scale is a “Forest plot”.
Each study is represented by a black square and a horizontal line
(CI:95%).
The area of the black square reflects the weight of the study / precision
of the study (roughly the sample size).
A logarithmic scale should be used for plotting the Relative Risk /
Odds Ratio.
Aggregate Effect size – displayed as a ‘diamond’.
48.
49. The impact of fish oil consumption on Cardio-vascular diseases
50. Look at the title of the forest plot, the intervention, outcome effect measure
of the investigation and the scale
The names on the left are the authors of the primary studies included in
the MA
The small squares represent the results of the individual trial results
The size of each square represents the weight given to each study in the
meta-analysis
The horizontal lines associated with each square represent the confidence
interval associated with each result
The vertical line represents the line of no effect, i.e. where there is no
statistically significant difference between the treatment/intervention
group and the control group
The pooled analysis is given a diamond shape. The horizontal width of the
diamond is the confidence interval
51. Effect of probiotics on the risk of antibiotic associated diarrhoea
D'Souza, A. L et al. BMJ 2002;324:1361
57. Reviews usually bring together studies that were performed
By different people
In different settings
In different countries
On different people
In different ways
For different lengths of time
To look at different outcomes
........… and these aren’t the only differences.
Assessing combinability
Types of heterogeneity:
•Clinical heterogeneity
•Methodological
heterogeneity
•Statistical heterogeneity
58. Test for existence of heterogeneity: have low power
▪ Cochrane’s Q – statistic based on chi-square test
▪ I2 statistic – scores heterogeneity between 0% and 100%
25% - low heterogeneity
50% - moderate
75% - high
Presence or absence of heterogeneity influences the subsequent method
of analysis:
▪ Fixed- effects model
▪ Random effect model
Meta-regression: to over come heterogeneity
59. FIXED EFFECTS MODEL
• Conduct, if heterogeneity is absent
• Assumes the size of treatment effect be
same (fixed) across all studies &
variation due to chance
• Pooling: Mantel Haenszel OR
• Weight = 1/variance
= 1/SE2
• When heterogeneity exists we get:
• a pooled estimate which may give too
much weight to large studies,
• a confidence interval which is too
narrow,
• a P-value which is too small.
RANDOM EFFECTS
MODEL
• Conduct, if heterogeneity is present
• Assumes that the size of treatment
effect does vary between studies
• Der Simonian Laird method (DSL)
for Odds’ Ratio
• Weight = 1/variance
= 1/(SE2+ inter-trial variance)
• When heterogeneity exists we get:
• possibly a different pooled estimate
with a different interpretation,
• a wider confidence interval,
• a larger P-value
60. FIXED EFFECTS MODEL
• When heterogeneity does not exists:
• a pooled estimate which is correct,
• a confidence interval which is correct,
• a P-value which is correct.
RANDOM EFFECTS
MODEL
• When heterogeneity does not exist:
• a pooled estimate which is correct,
• a confidence interval which is too wide,
• a P-value which is too large
No universally accepted method for choosing.
A reasonable approach:
1. Decide whether the assumption of a fixed effects model is plausible. Could the
studies all be estimating the same effect? If not, consider a random effects model.
2. If fixed effects assumption is plausible, are the data compatible?
Graphical methods: forest plot, Galbraith plot.
Analytical methods: heterogeneity test, I2 statistic.
If assumption looks compatible with the data, use fixed effects, otherwise consider
random effects.
61.
62. The estimate of study results is the dependent variable and
one or more study-level variables are the independent
variables (predictors)
Allows researchers to explore which types of patient-specific
factors or study design factors contribute to heterogeneity.
Limited ability to identify important factors – struggles to
identify which patient features are related to the size of
treatment effect.
63. Involves the central collection, checking and analysis of updated
Individual Patient Data
Include all properly randomised trials, published and unpublished
Include all patients in an intention-to-treat analysis
Analysis stratified by trial
IPD does not mean that all patients are combined into a single mega
trial; meta-analysis looks at the results within each study, and then
calculates a weighted average.
Obtaining individual patient data from each of the trials is
challenging
64. Collect raw data from related studies, whether or not the
studies collaborated at the design stage, exposures measures
and other covariates that can be applied uniformly across the
studies combined.
The major advantage of a IPD over an MA is the use of
individual-based rather than group-based data.
65.
66. Comprehensive search strategy: multiple sources of information
Explicit methodology: to ensure reproducibility and transparency
Emphasis on all clinically important outcomes: related to efficacy, safety,
and tolerability of the interventions under consideration
Limiting errors: two reviewers at all major steps; limits bias and improves
precision
67. 70
Good deal of effort
Qualitative distinctions between studies not captured
“Apples and oranges” criticism
A good meta-analysis of badly designed studies will still result in bad
statistics.
Selection bias
Analysis of between study differences is co-relational
Tend to look at ‘broad questions’ that may not be immediately
applicable to individual patients
Simpson’s paradox (two smaller studies may point in one direction,
and the combination study in the opposite direction)
68. Huge Checklist
[http://faculty.ucmerced.edu/wshadish/]
Free Software:
EpiMeta: from Epi Info
Revman: from Cochrane Collaboration
“meta” package in R for statistical computing
Non-free
meta module in STATA
69. PRISMA Statement (formerly QUOROM) : Preferred Reporting Items
for Systematic Reviews and Meta-Analyses
MOOSE Statement : proposal for reporting meta analyses of
observational studies in epidemiology
70.
71. Mantel-Haenszel methods have been shown to be more reliable when there are not
many data (small trials and not many of them). This is why they have been selected as
the principle method of meta-analysis in the Cochrane Collaboration. This method
(which can be used for OR, RR and RD) is the most appropriate for many Cochrane
reviews, and many Cochrane review groups use it as standard.
Peto method performs well with sparse data and is then the best choice, but when
events are common there is usually no preference to use it over the other methods. It is
not a good idea to use the Peto method when the treatment effect is very large, as the
result may be misleading. This method is also unsuitable if there are large imbalances
in the size of groups within trials.
Random effects model may be better when there is statistical heterogeneity between
the studies in your review (we will discuss this further in Module 13 on Heterogeneity).